Devika Das, Associate Professor of Medicine at the University of Florida College of Medicine, shared a post on LinkedIn:
“HER-2 testing in Non small cell lung cancer is often underrecognized and confusing.
Sharing brief thoughts on importance of testing along with our expert pathology colleague on this oncogene driven lung cancer which could be driving about 2-4% of all NSCLC diagnosed and is now targetable clinically!
Thank you, COR2ED, Rahul Gosain and Rohit Gosain for inviting us to have this nuanced discussion as it pertains to clinical utility and opportunities in this emerging space.”
